World-Renowned Children’s Hospital Adds New Six-Figure Contract for CynergisTek’s Red Team and Remediation Support Services
April 07 2022 - 7:00AM
Business Wire
One the nation’s top pediatric hospital engages CynergisTek for
penetration testing and advisory support services
CynergisTek (NYSE American: CTEK), leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, announces one of the leading pediatric and obstetric
hospitals in the pacific region has signed a six-figure contract
for Red Team services and advisory support. The hospital adds one
thousand hours of support throughout the next year.
CynergisTek’s Red Team performs external network penetration and
web application testing to evaluate the security posture of
clients. These security risk assessments provide valuable insight
into the effectiveness of an organization’s cybersecurity program
by identifying any gaps or vulnerabilities that cybercriminals may
exploit and recommending prioritized remediation steps.
CynergisTek’s Remediation Support Services provide clients with
advisory and hands-on support for the development and
implementation of these steps to strengthen their security program
maturity.
Lack of patching discipline was listed as one of the top
contributors to incidents and risk in healthcare IT according to
ECRI. “More and more health systems are realizing the benefits and
necessity of increasing the frequency and scope of their testing
activities,” said Mac McMillan, CEO of CynergisTek. “A control not
tested is a control not trusted, plain and simple. The hackers are
counting on organizations not testing, which is demonstrated by the
high number of attacks that occur because something wasn’t patched,
blocked, enabled, configured properly, you name it.”
Healthcare organizations like this west coast-based children’s
hospital understand the importance of validating their security
controls and processes to prevent cyberattacks and proactively
looking at potential threats. The agreement allows this client to
continue to rely on CynergisTek’s expertise and benefit from
guidance on how to remediate vulnerabilities in their
cybersecurity, privacy, compliance, and IT Audit programs.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity consulting firm
helping organizations in highly-regulated industries, including
those in healthcare, government, and finance navigate emerging
security and privacy issues. CynergisTek combines intelligence,
expertise, and a distinct methodology to validate a company's
security posture and ensure the team is rehearsed, prepared, and
resilient against threats. Since 2004, CynergisTek has been
dedicated to hiring and retaining experts who bring real-life
experience and hold advanced certifications to support and educate
the industry by contributing to relevant industry associations. For
more information, visit www.cynergistek.com or follow us on Twitter
or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of the COVID-19
pandemic, including actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets; the general economic impact
of the ongoing war in Ukraine, including the impact of related
sanctions being imposed by the U.S. Government and the governments
of other countries, and the impact of potential reprisals as a
consequence of the war in Ukraine and any related sanctions; and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Certain of these risks and uncertainties are
or will be described in greater detail in the Company’s Form 10-K
and Form 10-Q filings with the Securities and Exchange Commission,
which are available at http://www.sec.gov. Given the risks and
uncertainties, readers should not place undue reliance on any
forward-looking statement and should recognize that the statements
are predictions of future results which may not occur as
anticipated. Many of the risks listed above have been, and may
further be, exacerbated by the COVID-19 pandemic, including its
impact on the healthcare industry, or the ongoing war in Ukraine.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220407005379/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x7 InvestorRelations@cynergistek.com
CynergisTek Media Contact: CynergisTek, Inc. Trinity
McPherson (443) 853-8468 trinity.mcpherson@cynergistek.com
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Mar 2024 to Apr 2024
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Apr 2023 to Apr 2024